Certificate of analysis Current batch
IGF-LR3 1 mg Certificate of Analysis
Batch LLLR31126, tested November 12, 2026 by ILS Laboratories
Permanent Loti Labs archive copy. This file is preserved and is not overwritten when the customer-facing gallery changes.
Summary
This sample tested at 99.17% purity by HPLC. Its identity was confirmed by HPLC (retention time match), and endotoxin measured NMT 0.05 EU/mL. The certificate reports a content of 1.03 mg.
Results
- Purity
- 99.17%HPLC
- Identity
- ConfirmedHPLC (retention time match)
- Content
- 1.03 mgHPLC (net peptide content)
- Endotoxin
- NMT 0.05 EU/mL
Provenance
- Laboratory
- ILS LaboratoriesIndependent, U.S.-based third party
- Batch
- LLLR31126
- Report number
- COA-2026-RHR_9X
- Verification code
- JUHVZGUA
- Sample received
- November 2, 2026
- Report issued
- November 12, 2026
Match the batch number on your vial label to the one above. Earlier batches stay on record below.
Metadata was transcribed from the certificate and checked against the laboratory-hosted source when an exact record was available.
View the customer-facing Peptides certificates
or search the complete COA archive. Specifications and every published batch for this compound are on the IGF-1 LR3 compound profile.
Earlier batches of IGF-LR3 1 mg
| Tested | Batch | Purity | Laboratory | |
|---|---|---|---|---|
| Jun 17, 2026 | LL-LR3-526 | 99.8% | Bioviridian | View record |
Research use only. This certificate is provided strictly for laboratory, analytical and research reference.